ELICIO THERAPEUTICS I
5.0000
25-November-24 15:00:09
15 minutes delayed
Stocks
+0.0700
+1.42%
Today's range
4.9300 - 5.1000
ISIN
N/A
Source
NASDAQ
-
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
13 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 15:05:02 By Nasdaq GlobeNewswire
-
31 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grants
16 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grants
17 Sep 2024 07:31:00 By Nasdaq GlobeNewswire
-
13 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
13 Aug 2024 15:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
12 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
28 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces Proposed Public Offering
27 Jun 2024 15:05:00 By Nasdaq GlobeNewswire
-
27 Jun 2024 15:01:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grants
18 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
23 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15 May 2024 15:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
29 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
18 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >